Mixed Signals on Mammography

i-28888d98b874099d6961e8e6ee1f4de3-mammbuzz.jpg

Last month the US government released new guidelines for breast cancer screening mammography, a revision which Orac writes has "shaken my specialty to the core." For most women, the guidelines now recommend beginning biennial screenings at age fifty, instead of annual screenings at age forty. Around the same time, a study came out which "suggested that low dose radiation from mammography may put young women with breast cancer-predisposing BRCA mutations at a higher risk for breast cancer." Get some perspective on Respectful Insolence before breaking out the snake oil. Then visit Andrew Gelman on Applied Statistics, who reports that the Senate approved a health-care provision requiring insurance companies to offer free mammograms to women. Bemoaning the mixed signals, Gelman writes "none of this makes sense to me." And on On Becoming a Domestic and Laboratory Goddess, Dr. Isis wonders if the new guidelines are racially insensitive, considering statistics that show black women are "at a higher risk for developing cancer before 40" and face a lower 5-year survival rate.

Links below the fold.

More like this

Connected to my last post (and anticipated by my razor-sharp commenters), in this post I want to look at the pros and cons of routine screening mammography in women under age 50, drawing on the discussion of this subject in the multi-page "patient instructions" document I received from my primary…
I feel dense for not knowing this important public health fact: women with extremely dense breast tissue are at least four times more likely to develop breast cancer. Over the years, I've had my routine screening mammograms with stellar results.  No evidence of cancer in my two mammary glands.  I'…
On Terra Sigillata, Abel Pharmboy reports on "sporadic, worldwide shortages of Arimidex," a drug officially approved by the FDA for inhibiting hormonal transitions in breast cancer patients. But up to a thousand times more men use this drug than women, as a non-FDA-approved therapy for…
So it's not quite a colonoscopy on live TV, but Janet's done the public health world a favor and blogged her mammogram. However, one commenter notes: How about a discussion of the ethics of this particular screening method since it's fairly equivocal whether it's actually worth the hassle and…